공고 • Jun 30
Nanjing Red Sun Co.,Ltd. to Report First Half, 2026 Results on Aug 18, 2026 Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2026 results on Aug 18, 2026 Board Change • May 20
High number of new and inexperienced directors There are 10 new directors who have joined the board in the last 3 years. The company's board is composed of: 10 new directors. 2 experienced directors. No highly experienced directors. Employee Representative Supervisor Xiaosheng Yang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. 공고 • Apr 28
Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026 Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China 공고 • Mar 31
Nanjing Red Sun Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 공고 • Dec 31
Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 공고 • Sep 30
Nanjing Red Sun Co.,Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Nanjing Red Sun Co.,Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 공고 • Jul 02
Nanjing Red Sun Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 공고 • Apr 26
Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025 Nanjing Red Sun Co.,Ltd., Annual General Meeting, May 28, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China 공고 • Mar 31
Nanjing Red Sun Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 공고 • Dec 31
Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 공고 • Dec 29
Nanjing Red Sun Co.,Ltd. Approves Management Elections Nanjing Red Sun Co.,Ltd. at its Extraordinary General Meeting held on 25 December 2024, approved the election of Yang Yi, Hu Rongmao, Bao Qiongzao, Zhang Libing, Yang Bin and Cheng Yuan as non-independent director. The company approved the election of Mu Peilin and Wei Zhongxiong as independent director. The company approved the election of Fu Xuyao, Tao Biao and Zhou Zijun as shareholder supervisor. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.009 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.01 (up from CN¥0.009 in 3Q 2023). Revenue: CN¥1.06b (flat on 3Q 2023). Net income: CN¥5.52m (up 1.5% from 3Q 2023). Profit margin: 0.5% (in line with 3Q 2023). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.002 (vs CN¥0.012 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.002 (down from CN¥0.012 in 2Q 2023). Revenue: CN¥796.7m (down 6.8% from 2Q 2023). Net income: CN¥1.16m (down 83% from 2Q 2023). Profit margin: 0.1% (down from 0.8% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. New Risk • Jul 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change). 공고 • Jun 29
Nanjing Red Sun Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Nanjing Red Sun Co.,Ltd. announced that they will report first half, 2024 results on Aug 31, 2024 Reported Earnings • May 01
First quarter 2024 earnings released: EPS: CN¥0.035 (vs CN¥0.02 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.035 (up from CN¥0.02 in 1Q 2023). Revenue: CN¥845.7m (up 13% from 1Q 2023). Net income: CN¥20.1m (up 77% from 1Q 2023). Profit margin: 2.4% (up from 1.5% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. 공고 • May 01
Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024 Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 27, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China 공고 • Mar 30
Nanjing Red Sun Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Nanjing Red Sun Co.,Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 공고 • Dec 30
Nanjing Red Sun Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024 Nanjing Red Sun Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.009 (vs CN¥0.57 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.009 (down from CN¥0.57 in 3Q 2022). Revenue: CN¥1.05b (down 45% from 3Q 2022). Net income: CN¥5.43m (down 98% from 3Q 2022). Profit margin: 0.5% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year. Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥8.57, the stock trades at a trailing P/E ratio of 37.4x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years. New Risk • Sep 11
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risk Large one-off items impacting financial results. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.53 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.012 (down from CN¥0.53 in 2Q 2022). Revenue: CN¥855.1m (down 56% from 2Q 2022). Net income: CN¥6.70m (down 98% from 2Q 2022). Profit margin: 0.8% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. 공고 • Jun 02
Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023 Nanjing Red Sun Co.,Ltd., Annual General Meeting, Jun 21, 2023, at 14:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2022 profit distribution plan; to consider Reappointment of 2023 audit firm; to consider 2022 remuneration for directors, supervisors and senior management; to consider Shareholder return plan for the next three years from 2023 to 2025; and to consider other business matters. Valuation Update With 7 Day Price Move • May 25
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥8.27, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 6.4% over the past three years. Valuation Update With 7 Day Price Move • May 10
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥7.09, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Reported Earnings • Apr 29
Full year 2022 earnings released: EPS: CN¥1.26 (vs CN¥6.45 loss in FY 2021) Full year 2022 results: EPS: CN¥1.26 (up from CN¥6.45 loss in FY 2021). Revenue: CN¥6.44b (up 38% from FY 2021). Net income: CN¥732.3m (up CN¥4.48b from FY 2021). Profit margin: 11% (up from net loss in FY 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Board Change • Nov 16
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 31
Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.009 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.57 (up from CN¥0.009 in 3Q 2021). Revenue: CN¥1.90b (up 77% from 3Q 2021). Net income: CN¥328.5m (up CN¥322.7m from 3Q 2021). Profit margin: 17% (up from 0.5% in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.014 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.014 in 2Q 2021). Revenue: CN¥1.95b (up 77% from 2Q 2021). Net income: CN¥311.6m (up CN¥303.2m from 2Q 2021). Profit margin: 16% (up from 0.8% in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance. Reported Earnings • May 02
First quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.038 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.038 in 1Q 2021). Revenue: CN¥1.53b (up 78% from 1Q 2021). Net income: CN¥305.6m (up CN¥283.5m from 1Q 2021). Profit margin: 20% (up from 2.6% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Independent Director Zhen Yan is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 10
Full year 2021 earnings released: CN¥6.42 loss per share (vs CN¥0.27 loss in FY 2020) Full year 2021 results: CN¥6.42 loss per share (down from CN¥0.27 loss in FY 2020). Revenue: CN¥4.68b (up 16% from FY 2020). Net loss: CN¥3.73b (loss widened CN¥3.57b from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 01
Second quarter 2021 earnings released: EPS CN¥0.014 (vs CN¥0.10 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.10b (down 13% from 2Q 2020). Net income: CN¥8.41m (down 86% from 2Q 2020). Profit margin: 0.8% (down from 4.7% in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 17
Full year 2020 earnings released: CN¥0.24 loss per share (vs CN¥0.59 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: CN¥4.08b (down 12% from FY 2019). Net loss: CN¥140.7m (loss narrowed 59% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Feb 04
New 90-day low: CN¥5.30 The company is down 25% from its price of CN¥7.08 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥5.34 The company is down 28% from its price of CN¥7.38 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥6.04 The company is down 13% from its price of CN¥6.91 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 09
New 90-day low: CN¥6.80 The company is down 12% from its price of CN¥7.71 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total losses of CN¥535.5m, with earnings decreasing by CN¥895.4m from the prior year. Total revenue was CN¥3.48b over the last 12 months, down 40% from the prior year.